ER van Wering

1.7k total citations
16 papers, 1.1k citations indexed

About

ER van Wering is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, ER van Wering has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 11 papers in Hematology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in ER van Wering's work include Acute Lymphoblastic Leukemia research (11 papers), Acute Myeloid Leukemia Research (8 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). ER van Wering is often cited by papers focused on Acute Lymphoblastic Leukemia research (11 papers), Acute Myeloid Leukemia Research (8 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). ER van Wering collaborates with scholars based in Netherlands, United States and Germany. ER van Wering's co-authors include Jacques J. M. van Dongen, K. Hählen, A. Veerman, WA Kamps, MJ Willemse, A van der Does-van den Berg, Tomasz Szczepański, Ursula Creutzig, Henrik Hasle and Franco Locatelli and has published in prestigious journals such as Blood, Leukemia and PubMed.

In The Last Decade

ER van Wering

16 papers receiving 1.1k citations

Peers

Countries citing papers authored by ER van Wering

Since Specialization

Citations

This map shows the geographic impact of ER van Wering's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by ER van Wering with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites ER van Wering more than expected).

Fields of papers citing papers by ER van Wering

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by ER van Wering. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by ER van Wering. The network helps show where ER van Wering may publish in the future.

Co-authorship network of co-authors of ER van Wering

This figure shows the co-authorship network connecting the top 25 collaborators of ER van Wering. A scholar is included among the top collaborators of ER van Wering based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with ER van Wering. ER van Wering is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window study 2008 ·Leukemia ·Inge M. Appel, K.M. Kazemier, Joachim Boos, Claudia Lanvers, (unknown), A. Veerman, ER van Wering, Monique L. den Boer, Rob Pieters	90
2	The Prognostic Value of JAK2 Exon 16 Mutations in Children with Down Syndrome and Acute Lymphoblastic Leukemia. 2008 ·Blood ·Trudy Buitenkamp, (unknown), Marry van den Heuvel‐Eibrink, ER van Wering, Rob Pieters, C. Michel Zwaan	1
3	Ikaros Is a Frequently Affected Hematopoietic Differentiation Factor in Pediatric Relapse-Prone Precursor B-Cell Acute Lymphoblastic Leukemia 2008 ·Blood ·Roland P. Kuiper, Frank N. van Leeuwen, Vincent van der Velden, Simon V. van Reijmersdal, (unknown), (unknown), Jayne Y. Hehir‐Kwa, ER van Wering, Jacques J. M. van Dongen, Peter M. Hoogerbrugge, Ad Geurts van Kessel	2
4	Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL 2002 ·Leukemia ·(unknown), (unknown), (unknown), W M Comans-Bitter, MJ Willemse, K. Hählen, WA Kamps, ER van Wering, Jacques J. M. van Dongen	108
5	T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis 2002 ·Leukemia ·(unknown), J M Wijkhuijs, (unknown), ER van Wering, Jacques J. M. van Dongen	89
6	t(7;12)(q36;p13) and t(7;12)(q32;p13) – translocations involving ETV6 in children 18 months of age or younger with myeloid disorders 2001 ·Leukemia ·R Släter, (unknown), (unknown), D. Olde Weghuis, Eva van den Berg, (unknown), A van der Does-van den Berg, ER van Wering, K. Hählen, AJ Carroll, SC Raimondi, (unknown)	44
7	Extramedullary infiltrates at diagnosis have no prognostic significance in children with acute myeloid leukaemia 2001 ·Leukemia ·(unknown), Tom Révész, Marc Bierings, (unknown), ER van Wering, K. Hählen, A van der Does-van den Berg	57
8	Fusion of the homeobox gene HLXB9 and the ETV6 gene in infant acute myeloid leukemias with the t(7;12)(q36;p13). 2001 ·PubMed ·H. Berna Beverloo, Ioannis Panagopoulos, M. Isaksson, ER van Wering, Ellen van Drunen, Annelies de Klein, B Johansson, Rosalyn Slater	52
9	Precursor-B-ALL with DH–JH gene rearrangements have an immature immunogenotype with a high frequency of oligoclonality and hyperdiploidy of chromosome 14 2001 ·Leukemia ·Tomasz Szczepański, MJ Willemse, ER van Wering, (unknown), WA Kamps, Jacques J. M. van Dongen	72
10	T cell receptor gamma (TCRG) gene rearrangements in T cell acute lymphoblastic leukemia reflect ‘end-stage’ recombinations: implications for minimal residual disease monitoring 2000 ·Leukemia ·Tomasz Szczepański, (unknown), MJ Willemse, I L Wolvers-Tettero, ER van Wering, Jacques J. M. van Dongen	39
11	Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984–1991 2000 ·Leukemia ·WA Kamps, A. Veerman, ER van Wering, (unknown), R Släter, A van der Does-van den Berg	50
12	Childhood acute lymphoblastic leukemia in the Netherlands - Randomized studies and nationwide treatment results from 1972 to 1995 1998 ·(unknown), A. Veerman, ER van Wering, (unknown), (unknown), (unknown), (unknown), Willem A. Kamps	6
13	Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS) 1997 ·Blood ·Charlotte M. Niemeyer, Maurizio Aricò, Giuseppe Basso, Andrea Biondi, A. Cantù Rajnoldi, Ursula Creutzig, Oskar A. Haas, Jochen Harbott, Henrik Hasle, Gitte Kerndrup, Franco Locatelli, G. Bruce Mann, B. Stollmann-Gibbels, E. T. van’t Veer-Korthof, ER van Wering, Martin Zimmermann	283
14	Breakpoint heterogeneity in t(10;11) translocation in AML-M4/M5 resulting in fusion of AF10 and MLL is resolved by fluorescent in situ hybridization analysis. 1995 ·PubMed ·H. Berna Beverloo, Maryvonne Le Coniat, (unknown), (unknown), Olivier Bernard, Annelies de Klein, ER van Wering, (unknown), Bryan D. Young, A Hagemeijer	69
15	In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia 1995 ·Blood ·E. Klumper, Rob Pieters, A. Veerman, (unknown), (unknown), K. Hählen, Gertjan J.L. Kaspers, ER van Wering, R. Hartmann, G. Henze	167
16	Cytoplasmic expression of the CD3 antigen as a diagnostic marker for immature T-cell malignancies 1988 ·Blood ·JJ van Dongen, (unknown), IL Wolvers-Tettero, W M Comans-Bitter, H. J. Adriaansen, Herbert Hooijkaas, ER van Wering, Cox Terhorst	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact